Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR.

Hum Mol Genet. 2009 Feb 15;18(4):767-78. doi: 10.1093/hmg/ddn388. Epub 2008 Nov 14.

2.

Association to the Glypican-5 gene in multiple sclerosis.

Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF.

J Neuroimmunol. 2010 Sep 14;226(1-2):194-7. doi: 10.1016/j.jneuroim.2010.07.003. Epub 2010 Aug 6.

PMID:
20692050
3.

Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.

Shin JG, Kim HJ, Park BL, Bae JS, Kim LH, Cheong HS, Shin HD.

J Neurol Sci. 2013 Dec 15;335(1-2):82-8. doi: 10.1016/j.jns.2013.08.031. Epub 2013 Aug 30.

PMID:
24135429
4.

Glypican 5 is an interferon-beta response gene: a replication study.

Cénit MD, Blanco-Kelly F, de las Heras V, Bartolomé M, de la Concha EG, Urcelay E, Arroyo R, Martínez A.

Mult Scler. 2009 Aug;15(8):913-7. doi: 10.1177/1352458509106509. Epub 2009 Jun 25.

PMID:
19556317
5.

Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.

Matesanz F, González-Pérez A, Lucas M, Sanna S, Gayán J, Urcelay E, Zara I, Pitzalis M, Cavanillas ML, Arroyo R, Zoledziewska M, Marrosu M, Fernández O, Leyva L, Alcina A, Fedetz M, Moreno-Rey C, Velasco J, Real LM, Ruiz-Peña JL, Cucca F, Ruiz A, Izquierdo G.

PLoS One. 2012;7(5):e36140. doi: 10.1371/journal.pone.0036140. Epub 2012 May 3.

6.

Genomewide admixture study in Mexican Mestizos with multiple sclerosis.

Ordoñez G, Romero S, Orozco L, Pineda B, Jiménez-Morales S, Nieto A, García-Ortiz H, Sotelo J.

Clin Neurol Neurosurg. 2015 Mar;130:55-60. doi: 10.1016/j.clineuro.2014.11.026. Epub 2014 Dec 24.

PMID:
25577161
7.

Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.

Arking DE, Reinier K, Post W, Jui J, Hilton G, O'Connor A, Prineas RJ, Boerwinkle E, Psaty BM, Tomaselli GF, Rea T, Sotoodehnia N, Siscovick DS, Burke GL, Marban E, Spooner PM, Chakravarti A, Chugh SS.

PLoS One. 2010 Mar 25;5(3):e9879. doi: 10.1371/journal.pone.0009879.

8.

Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.

Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C, Bahlo M, Perera D, Johnson LJ, Tait BD, Varney MD, Speed TP, Taylor BV, Foote SJ, Butzkueven H, Kilpatrick TJ.

Genes Immun. 2008 Oct;9(7):624-30. doi: 10.1038/gene.2008.59. Epub 2008 Jul 24.

PMID:
18650830
9.

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.

Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL.

Nat Rev Genet. 2008 Jul;9(7):516-26. doi: 10.1038/nrg2395. Epub 2008 Jun 10. Review.

PMID:
18542080
10.

Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms.

Comabella M, Craig DW, Camiña-Tato M, Morcillo C, Lopez C, Navarro A, Rio J; BiomarkerMS Study Group., Montalban X, Martin R.

PLoS One. 2008;3(10):e3490. doi: 10.1371/journal.pone.0003490. Epub 2008 Oct 22.

11.

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.

Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, Corcia P, Otaegui D, Antigüedad A, Alcina A, Comabella M, Montalban X, Olascoaga J, Matesanz F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Rieckmann P, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Fontaine B, Zipp F, Vandenbroeck K, Bertram L.

J Med Genet. 2013 Mar;50(3):140-3. doi: 10.1136/jmedgenet-2012-101411. Epub 2013 Jan 12. No abstract available.

PMID:
23315543
12.

A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex.

Davies RW, Wells GA, Stewart AF, Erdmann J, Shah SH, Ferguson JF, Hall AS, Anand SS, Burnett MS, Epstein SE, Dandona S, Chen L, Nahrstaedt J, Loley C, König IR, Kraus WE, Granger CB, Engert JC, Hengstenberg C, Wichmann HE, Schreiber S, Tang WH, Ellis SG, Rader DJ, Hazen SL, Reilly MP, Samani NJ, Schunkert H, Roberts R, McPherson R.

Circ Cardiovasc Genet. 2012 Apr 1;5(2):217-25. doi: 10.1161/CIRCGENETICS.111.961243. Epub 2012 Feb 7.

13.

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

Schmidt S, Barcellos LF, DeSombre K, Rimmler JB, Lincoln RR, Bucher P, Saunders AM, Lai E, Martin ER, Vance JM, Oksenberg JR, Hauser SL, Pericak-Vance MA, Haines JL; Multiple Sclerosis Genetics Group..

Am J Hum Genet. 2002 Mar;70(3):708-17. Epub 2002 Feb 11.

14.

Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.

Ma GZ, Stankovich J; Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)., Kilpatrick TJ, Binder MD, Field J.

PLoS One. 2011 Feb 8;6(2):e16964. doi: 10.1371/journal.pone.0016964.

15.

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.

Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Johnson LJ, Wilkins E, Field J, Danoy P, Brown MA; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)., Rubio JP, Butzkueven H.

PLoS One. 2010 Apr 2;5(4):e10003. doi: 10.1371/journal.pone.0010003.

16.

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.

Khankhanian P, Matsushita T, Madireddy L, Lizée A, Din L, Moré JM, Gourraud PA, Hauser SL, Baranzini SE, Oksenberg JR.

BMC Med Genet. 2015 Jul 28;16:55. doi: 10.1186/s12881-015-0201-2.

17.

Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.

Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, Müller-Sarnowski F, Pfister H, Roeske D, Rieckmann P, Hemmer B, Ising M, Uhr M, Bettecken T, Holsboer F, Müller-Myhsok B, Weber F.

J Neuroimmunol. 2010 Oct 8;227(1-2):162-6. doi: 10.1016/j.jneuroim.2010.06.003. Epub 2010 Jul 2.

PMID:
20598377
18.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, Zhang ZF, Christiani DC, Wu X, Yang P.

Lancet Oncol. 2010 Apr;11(4):321-30. doi: 10.1016/S1470-2045(10)70042-5. Epub 2010 Mar 19.

19.

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Patsopoulos NA; Bayer Pharma MS Genetics Working Group.; Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist.; ANZgene Consortium.; GeneMSA.; International Multiple Sclerosis Genetics Consortium., Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalbán J, Polman CH, Freedman MS, Hartung HP, Arnason BG, Comi G, Cook S, Filippi M, Goodin DS, Jeffery D, O'Connor P, Ebers GC, Langdon D, Reder AT, Traboulsee A, Zipp F, Schimrigk S, Hillert J, Bahlo M, Booth DR, Broadley S, Brown MA, Browning BL, Browning SR, Butzkueven H, Carroll WM, Chapman C, Foote SJ, Griffiths L, Kermode AG, Kilpatrick TJ, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard RN, Pender MP, Perreau VM, Perera D, Rubio JP, Scott RJ, Slee M, Stankovich J, Stewart GJ, Taylor BV, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi FM, Compston A, Haines J, Hauser SL, McCauley J, Ivinson A, Oksenberg JR, Pericak-Vance M, Sawcer SJ, De Jager PL, Hafler DA, de Bakker PI.

Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609. Erratum in: Ann Neurol. 2013 Apr;73(4):561.

20.

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD, Tanzi RE.

Am J Hum Genet. 2008 Nov;83(5):623-32. doi: 10.1016/j.ajhg.2008.10.008. Epub 2008 Oct 30.

Supplemental Content

Support Center